Cargando…
SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML
Our previous studies demonstrated that INPP4B, a member of the PI3K/Akt signaling pathway, is overexpressed in a subset of AML patients and is associated with lower response to chemotherapy and shorter survival. INPP4B expression analysis in AML revealed a right skewed frequency distribution with 25...
Autores principales: | Dzneladze, Irakli, Woolley, John F., Rossell, Carla, Han, Youqi, Rashid, Ayesha, Jain, Michael, Reimand, Jüri, Minden, Mark D., Salmena, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802890/ https://www.ncbi.nlm.nih.gov/pubmed/29415082 http://dx.doi.org/10.1371/journal.pone.0191510 |
Ejemplares similares
-
Correction: SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML
Publicado: (2018) -
Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts
por: Mangialardi, Emily Marie, et al.
Publicado: (2019) -
ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins
por: Krassowski, Michal, et al.
Publicado: (2018) -
A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALC
por: Brand, Jaap, et al.
Publicado: (2013) -
miR-133 regulates Evi1 expression in AML cells as a potential therapeutic target
por: Yamamoto, Haruna, et al.
Publicado: (2016)